Key Highlights
•
A new study identifies a specific chemical modification (phosphorylation) of the enzyme PHGDH, driven by the protein WNK1, as a key marker in gastric cancer. This finding is significant because it could help doctors predict which patients are most likely to benefit from a common chemotherapy drug, oxaliplatin, offering a potential tool for personalized treatment.
Source →
•
When human gut bacteria are grown together in pairs, they undergo massive changes in the proteins they produce and the small molecules they release. This extensive remodeling shows how the simple presence of another bacterial species can fundamentally alter a microbe’s metabolism, which is crucial for understanding the complex interactions within our gut microbiome.
Source →
•
Researchers have discovered that Shiga toxin, produced by harmful E. coli bacteria, helps the pathogen colonize the gut by speeding up the host’s intestinal movement, which flushes out resident beneficial microbes. This reveals a previously unknown strategy where a toxin directly manipulates the host’s physiology to give the invading bacteria a competitive advantage.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
